Antenatal Screening for down's Syndrome—Can We Do Better?

Cuckle HS Wald NJ Thompson SG Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein. Br J Obstet Gynae 1987; 94: 387–402

Palomaki GE Haddow JE Maternal serum alpha-fetoprotein, age and Down's syndrome risk. Am J Obstet Gynae 1987; 156: 460–3

DiMaio MS Baumgarten A Greenstein RM Saal HM Mahoney MJ Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels. New Engl J Med 1987; 317: 342–6

White I Paphia SS Magnay D Improving methods of screening for Down's syndrome. New Engl J Med 1989; 320: 401–2

Wald NJ Cuckle HS Densem JW Nanchalal K Royston P Chard T Maternal serum screening for Down's syndrome in early pregnancy. BMJ 1988; 297: 883–7

Sturgeon CM Seth J Al-Sadie R EQA for tumour markers: strategy in the United Kingdom. J Tumor Marker Oncology 1992; 7: 91–102

Macri JN Kasturi RV Krantz DA Cook EJ Moore ND Young JA Maternal serum Down syndrome screening: free beta protein is a more effective marker than human chorionic gonadotrophin. Am J Obstet Gynae 1990; 163: 1248–53

Macri JN Kasturi BE Krantz BS Cook EJ Sunderji SG Larsen JW Maternal serum Down syndrome screening: unconjugated oestriol is not useful. Am J Obstet Gynae 1990; 162: 672–3

Reynolds TM Penney MD The mathematical basis of multivariate risk screening: with special reference to screening for Down's syndrome associated pregnancy. Ann Clin Biochem 1989; 27: 452–8

Wald NJ Cuckle HS Densem JW Kennard A Smith D Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustments for maternal weight. Br J Obstet Gynae 1992; 99: 144–9

Wald NJ Kennard A Densem JW Cuckle HS Chard T Butler L Antenatal maternal serum screening for Down's syndrome: results of a demonstration project. BMJ 1992; 305: 391–4

Ellis AR Al-Sadie R Seth J Pilot EQAS for screening for Down's syndrome. Commun Lab Med 1992; 3: 33–6

Wald NJ Cuckle HS Boreham J Terzian E The effect of maternal weight on maternal serum alpha-fetoproetin levels. Br J Obstet Gynae 1981; 88: 1094–6

Drugan A Dvorin E Johnson M Uhlman WR Evans MI The inadequacy of the current correction for maternal weight in MSAFP interpretation. Am J Hum Genet 1989; 45: A258

Reynolds TM Penney MD Hughes H John R The effect of weight correction on risk calculation for Down's syndrome screening. Ann Clin Biochem 1991; 28: 245–9

Petrocik E Wassman E Kelly J Prenatal screening for Down's syndrome with maternal serum HCG levels. Am J Obstet Gynae 1989; 161: 1168–73

UK collaborative study on alpha-fetoprotein in relation to neural tube defects. Lancet 1977; i: 1323–32

Special report: Maternal serum alpha-fetoprotein screening for neural tube defects: results of a consensus meeting. Prenat Diag 1985; 5: 77–81